Juguilon, Wilma D.

HRN: 25-46-88  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/13/2024
CEFTRIAXONE 1G (VIAL)
07/13/2024
07/20/2024
IVTT
1g
Q12
Breast Mass
Waiting Final Action 
07/13/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
07/13/2024
07/20/2024
IVTT
600mg
Q6
Breast Mass
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: